1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. Financials
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 93,34 07910 8174 072--
Enterprise Value (EV)1 3353 8369 7561 563717-278
P/E ratio -0,72x-15,3x-6,10x2,18x4,89x10,1x
Yield ------
Capitalization / Revenue 5,00x8,58x9,44x0,95x1,26x2,08x
EV / Revenue 18,0x8,07x8,51x0,36x0,22x-0,14x
EV / EBITDA ------
Price to Book -0,69x12,6x-30,9x2,44x1,52x1,15x
Nbr of stocks (in thousands) 23 44936 57875 60878 135--
Reference price (USD) 3,9811214352,152,152,1
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 18,74761 1464 2853 2261 958
EBITDA ------
Operating profit (EBIT)1 -130-417-1 6872 1041 049540
Operating Margin -694%-87,6%-147%49,1%32,5%27,6%
Pre-Tax Profit (EBT)1 -133-418-1 7152 0871 038535
Net income1 -133-418-1 7441 969902416
Net margin -711%-87,9%-152%46,0%27,9%21,2%
EPS2 -5,51-7,27-23,423,910,65,16
Dividend per Share ------
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 1792227049991 1511 404
EBITDA ------
Operating profit (EBIT)1 -307-825209477595804
Operating Margin -172%-371%29,7%47,8%51,7%57,2%
Pre-Tax Profit (EBT)1 -316-830206473590799
Net income1 -322-846203440559749
Net margin -180%-381%28,9%44,1%48,5%53,4%
EPS2 -4,31-11,22,565,336,758,99
Dividend per Share ------
Announcement Date 11/04/202102/28/202205/09/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 242-----
Net Cash position1 -2431 0612 5083 3544 349
Leverage (Debt / EBITDA) ------
Free Cash Flow1 -138-97,22651 853726358
ROE (Net Profit / Equities) --190%-1 266%258%33,9%19,2%
Shareholders' equity1 -2211387642 6632 162
ROA (Net Profit / Asset) -74,4%-47,7%-83,8%58,8%19,3%12,8%
Assets1 1788782 0803 3484 6803 242
Book Value Per Share2 -5,758,84-4,6421,434,345,3
Cash Flow per Share ------
Capex1 1,8622057,564,350,643,9
Capex / Sales 9,95%46,3%5,01%1,50%1,57%2,24%
Announcement Date 03/11/202003/01/202102/28/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 4 071 593 745
Net sales (USD) 1 146 290 000
Number of employees 1 541
Sales / Employee (USD) 743 861
Free-Float 99,0%
Free-Float capitalization (USD) 4 029 035 600
Avg. Exchange 20 sessions (USD) 328 645 639
Average Daily Capital Traded 8,07%
EPS & Dividend
Year-on-year evolution of the PER